MBX Biosciences (MBX) Prepaid Assets (2023 - 2026)

MBX Biosciences' (MBX) quarterly Prepaid Assets came in at $8.6 million in Q1 2026, up 1267.25% year-on-year from $626000.0 in Q1 2025, and up 9.25% quarter-over-quarter from $7.8 million in Q4 2025.

MBX Biosciences (MBX) Prepaid Assets (2023 - 2026) Analysis & Trends

MBX Biosciences has disclosed Prepaid Assets across 4 years of filings, most recently posting $8.6 million for Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $8.6 million, up 1267.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.6 million (up 1267.25% YoY), and the FY2025 annual result was $7.8 million, up 52.5% from the prior year.
  • Prepaid Assets came in at $8.6 million for Q1 2026 at MBX Biosciences, up from $7.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q1 2026 to a low of $133000.0 in Q4 2023.
  • The 4-year median for Prepaid Assets is $860000.0 (2024), against an average of $3.1 million.
  • Across the five-year window, Prepaid Assets soared 3762.41% in 2024 and advanced 5.25% in 2025, its largest moves.
  • MBX Biosciences' Prepaid Assets stood at $133000.0 in 2023, then jumped by 3762.41% to $5.1 million in 2024, then soared by 52.5% to $7.8 million in 2025, then gained by 9.25% to $8.6 million in 2026.
  • The last three Prepaid Assets figures came in at $8.6 million (Q1 2026), $7.8 million (Q4 2025), and $882000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 MBX Biosciences 1.44 Bn 1.44 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 8.56 Mn
Dec 31, 2025 7.83 Mn
Sep 30, 2025 882,000.00
Jun 30, 2025 472,000.00
Mar 31, 2025 626,000.00
Dec 31, 2024 5.14 Mn
Sep 30, 2024 838,000.00
Dec 31, 2023 133,000.00